Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients

Paolo Cravedi, Miguel Fribourg, Weijia Zhang, Zhengzi Yi, Elena Zaslavsky, German Nudelman, Lisa Anderson, Susan Hartzell, Sophie Brouard, Peter S. Heeger

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Tacrolimus (Tac) is an effective anti-rejection agent in kidney transplantation, but its off-target effects make withdrawal desirable. Although studies indicate that Tac can be safely withdrawn in a subset of kidney transplant recipients, immune mechanisms that underlie successful vs unsuccessful Tac removal are unknown. We performed microarray analyses of peripheral blood mononuclear cells (PBMC) RNA from subjects enrolled in the Clinical Trials in Organ Transplantation-09 study in which we randomized stable kidney transplant recipients to Tac withdrawal or maintenance of standard immunosuppression beginning 6 months after transplant. Eight of 14 subjects attempted but failed withdrawal, while six developed stable graft function for ≥2 years on mycophenolate mofetil plus prednisone. Whereas failed withdrawal upregulated immune activation genes, successful Tac withdrawal was associated with a downregulatory and proapoptotic gene program enriched within T cells. Functional analyses suggested stronger donor-reactive immunity in subjects who failed withdrawal without evidence of regulatory T cell dysfunction. Together, our data from a small, but unique, patient cohort support the conclusion that successful Tac withdrawal is not simply due to absence of donor-reactive immunity but rather is associated with an active immunological process.

Original languageEnglish
Pages (from-to)3477-3485
Number of pages9
JournalAmerican Journal of Transplantation
Issue number12
StatePublished - Dec 2020


  • genomics
  • immunobiology
  • immunosuppressant - calcineurin inhibitor: tacrolimus
  • immunosuppression/immune modulation
  • kidney (allograft) function/dysfunction
  • translational research/science


Dive into the research topics of 'Distinct peripheral blood molecular signature emerges with successful tacrolimus withdrawal in kidney transplant recipients'. Together they form a unique fingerprint.

Cite this